Bausch Health reports Q3 2023 results; specific figures not available in submitted text

Bausch Health Companies Inc.

2023-Q3 EPS reported -$1.52 revenue$6,349,000,000

Press release issued on Nov 2, 2023 for quarter ended Sep 30, 2023.
Exhibit 99.1 containing financial details was not included in submitted text.
Confidence is low due to missing exhibit content; no specific numbers available.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Bausch Health Companies Inc. reported financial results for the quarter ended September 30, 2023.

Period: the quarter ended September 30, 2023
Result: reported results

Exact text from the filing

On November 2, 2023, Bausch Health Companies Inc. (the “Company”) issued a press release announcing results of operations for the quarter ended September 30, 2023 and certain other financial information as of and for the quarter ended September 30, 2023.

View on SEC.gov

Browse all earnings releases →

Bausch Health Companies Inc. filing history →

Source: SEC EDGAR

accession 0000885590-23-000032

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.